Your session is about to expire
← Back to Search
Maintaining Patency in Implanted Port Catheters
N/A
Waitlist Available
Led By Sarah Pelgen, BSN, RN, OCN
Research Sponsored by TriHealth Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a saline and heparin combo is better than saline alone for flushing implanted port catheters to prevent obstruction.
Eligible Conditions
- Indwelling Catheter Complications
- Catheter Obstruction
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Participants With First Cathflo Administration for Occlusion (Blockage) Within 1 Year
Tubal Occlusion
Number of Participants With First Partial Occlusion Within 1 Year
Secondary study objectives
Number of Participants With First Complete or Partial Occlusion Within 1 Year
Number of Participants With HIT Within 1 Year
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Saline-only catheter flush - The intervention group will have their port catheters flushed with saline only.
Group II: Control GroupActive Control1 Intervention
Heparinized saline catheter flush - The control group will have their port catheters flushed with 20mL saline + 5mL heparin 100 units/mL; q 3 months
Find a Location
Who is running the clinical trial?
TriHealth Inc.Lead Sponsor
99 Previous Clinical Trials
53,387 Total Patients Enrolled
Sarah Pelgen, BSN, RN, OCNPrincipal InvestigatorTriHealth Cancer Institute